DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Torsemide (Torsemide) - Hypertensive Crisis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypertensive Crisis (19)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torsemide where reactions include hypertensive crisis. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Torsemide side effects in 45 year old male

Reported by a physician on 2012-05-30

Patient: 45 year old male

Reactions: Vomiting, Nausea, Hyperkalaemia, Hyperglycaemia, Hypotension, Blood Fibrinogen Increased, Treatment Noncompliance, Hypertensive Crisis, Carotid Artery Stenosis, Renal Failure, Glycosylated Haemoglobin Increased, Fluid Intake Reduced, Vertigo, Influenza

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleglitazar (Aleglitazar)
    Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interrupted, frequency qd, or
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15
    End date: 2011-07-15

Aleglitazar (Aleglitazar)
    Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interrupted, frequency qd, or
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Torsemide
    Dosage: 10;40 g (10;20 mg, 1 in 1;2 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-08-23

Torsemide
    Dosage: 10;40 g (10;20 mg, 1 in 1;2 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Spironolactone
    Dosage: 125 mg (125 mg, 1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-04
    End date: 2011-05-06

Other drugs received by patient: Clopidogrel Bisulfate; Catapressan (Clonidine Hydrochloride); Inegy (Ezetimibe, Simvasatin); Aliskiren (Aliskiren Fumarate); Hydrochlorothiazide; Nitrolingual (Nitroglycerin); Diovan; Tramabeta (Tramadol Hydrochloride); Aspirin; Nebivolol HCL; Allopurinol; Vilodagliptin (Vildagliptin); Amlodipine; Metfformin Hydrochloride; Liprogol (Lispro Insulin); Pantoprazole; Levemir; Omega-3 Acid Ethyl Esgters (Omega-3 Acid Ethyl Esters); Targin (Naloxone Hydrochloride, Oxycodone Hydrochloride)



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-23

Patient: male

Reactions: Carotid Artery Stenosis, Hyperkalaemia, Hypertensive Crisis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Aleglitazar and Blinded Aleglitazar
    Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis

Spironolactone
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-04
    End date: 2011-05-06

Spironolactone

Torsemide

Torsemide
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Other drugs received by patient: Tramabeta; Nebivolol HCL; Ezetimibe; Vildagliptin; Liprolog; Omega-3-Acid Ethyl Esters; Aliskiren; Nitrolingual; Opium / Naloxone TAB; Clopidogrel; Amlodipine; Levemir; Allopurinol; Pantoprazole; Amlodipine; Nitrolingual; Metformin HCL; Aspirin; Amlodipine; Hydrochlorothiazide; Catapres; Diovan; Diovan



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-14

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Dyspnoea, Refractory Anaemia, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Albumin Urine Present, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Lercanidipine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Diovan HCT
    Dosage: 160/12.5 mg per day
    Administration route: Oral
    Indication: Hypertension

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Other drugs received by patient: Diuretics; Insulin Human; Adenuric; Nebivolol HCL; Simvastatin; Aspirin; Humalog; Pantoprazole; Metformin HCL; Other Antihypertensives; Simvastatin



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-14

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Dyspnoea, Refractory Anaemia, Gout, Diabetic Foot, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Albumin Urine Present, Hypertensive Crisis, Creatinine Urine Increased, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Diovan HCT
    Dosage: 160/12.5 mg per day
    Administration route: Oral
    Indication: Hypertension

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Lercanidipine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Other drugs received by patient: Aspirin; Pantoprazole; Other Antihypertensives; Simvastatin; Nebivolol HCL; Humalog; Simvastatin; Metformin HCL; Insulin Human; Adenuric; Diuretics



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-04

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Refractory Anaemia, Dyspnoea, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Diovan HCT
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Hypertension

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Lercanidipine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Other drugs received by patient: Humalog; Adenuric; Metformin HCL; Simvastatin; Insulin Human; Simvastatin; Pantoprazole; Diuretics; Aspirin; Nebivolol HCL; Other Antihypertensives



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-04

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Dyspnoea, Refractory Anaemia, Angina Pectoris, Gout, Diabetic Foot, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Diovan HCT
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Hypertension

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Carmen
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Other drugs received by patient: Diuretics; Other Antihypertensives; Nebivolol HCL; Aspirin; Simvastatin; Pantoprazole; Metformin HCL; Insulin Human; Adenuric; Humalog; Simvastatin



Possible Torsemide side effects in 45 year old male

Reported by a physician on 2012-04-13

Patient: 45 year old male

Reactions: Blood Creatine Phosphokinase Increased, Vomiting, Hyperkalaemia, Nausea, Hyperglycaemia, Blood Fibrinogen Increased, Hypertensive Crisis, Carotid Artery Stenosis, Gamma-Glutamyltransferase Increased, Vertigo, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-04

Aleglitazar (Aleglitazar)
    Dosage: last dose prior to hyperkalaemia:04jul2011, dose blinded, temporarily interrupted, frequency qd, ora
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Aleglitazar (Aleglitazar)
    Dosage: last dose prior to hyperkalaemia:04jul2011, dose blinded, temporarily interrupted, frequency qd, ora
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2010-01-08
    End date: 2011-05-09

Aleglitazar (Aleglitazar)
    Dosage: last dose prior to hyperkalaemia:04jul2011, dose blinded, temporarily interrupted, frequency qd, ora
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-08-11

Torsemide
    Dosage: 10 mg (10 mg, 1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Other drugs received by patient: Pantoprazole; Metformin HCL; Aliskiren (Aliskiren Fumarate); Catapressan (Clonidine Hydrochloride); Amlodipine; Allopurinol; Levemir; Vildagliptin (Vildagliptin); Nitrolingual (Nitroglycerin); Clopidogrel Bisulfate; Nebivolol HCL; Hydrochlorothiazide; Inegy (Ezetimibe, Simvastatin); Liprolog (Lispro Insulin); Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters); Diovan; Aspirin



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-04-05

Patient: male

Reactions: Carotid Artery Stenosis, Hyperkalaemia, Treatment Noncompliance, Hypertensive Crisis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Aleglitazar
    Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis

Torsemide
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Spironolactone
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Amlodipine; Liprolog; Catapres; Amlodipine; Ezetimibe; Metformin HCL; Omega-3-Acid Ethyl Esters; Nitrolingual; Clopidogrel; Allopurinol; Pantoprazole; Levemir; Aspirin; Nebivolol HCL; Vildagliptin; Nitrolingual; Diovan; Hydrochlorothiazide; Diovan; Aliskiren



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-03-22

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Intracardiac Thrombus, Left Ventricular Failure, Hypertensive Crisis, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Torsemide
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-01-01

Procoralan
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-01-01

Rasilez
    Administration route: Oral
    Indication: Hypertension

Falithrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Thrombophlebitis Superficial
    Start date: 2009-01-01

Diovan HCT
    Dosage: 80 /25 mg, daily
    Indication: Cardiac Failure
    Start date: 2008-01-01

Fluvastatin Sodium
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-01-01

Glimepiride
    Dosage: 4 mg , daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2008-01-01

Bisoprolol Fumarate
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2008-01-01

Rasilez
    Dosage: 150 mg, daily
    End date: 2012-01-17

Diovan HCT
    Dosage: 160 /25 mg, daily

Diovan HCT
    Dosage: 320/25 mg, daily

Metformin HCL
    Dosage: 2000 mg, daily
    Start date: 2008-01-01

Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-03-22

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Left Ventricular Failure, Intracardiac Thrombus, Hypertensive Crisis, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diovan HCT
    Dosage: 80 /25 mg, daily
    Indication: Cardiac Failure
    Start date: 2008-01-01

Procoralan
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-01-01

Falithrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Thrombophlebitis Superficial
    Start date: 2009-01-01

Rasilez
    Administration route: Oral
    Indication: Hypertension

Fluvastatin Sodium
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-01-01

Torsemide
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-01-01

Glimepiride
    Dosage: 4 mg , daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2008-01-01

Metformin HCL
    Dosage: 2000 mg, daily
    Start date: 2008-01-01

Diovan HCT
    Dosage: 320/25 mg, daily

Bisoprolol Fumarate
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2008-01-01

Rasilez
    Dosage: 150 mg, daily
    End date: 2012-01-17

Diovan HCT
    Dosage: 160 /25 mg, daily

Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants



Possible Torsemide side effects in male

Reported by a individual with unspecified qualification from Germany on 2012-03-15

Patient: male

Reactions: Carotid Artery Stenosis, Hyperkalaemia, Hypertensive Crisis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Aleglitazar
    Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis

Torsemide
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Spironolactone
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Aspirin; Amlodipine; Liprolog; Hydrochlorothiazide; Aliskiren; Nitrolingual; Metformin HCL; Omega-3-Acid Ethyl Esters; Clopidogrel; Levemir; Vildagliptin; Nebivolol HCL; Nitrolingual; Diovan; Diovan; Ezetimibe; Amlodipine; Allopurinol; Catapres; Pantoprazole



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-03-14

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Coronary Artery Thrombosis, Left Ventricular Failure, Hypertensive Crisis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Rasilez
    Administration route: Oral
    Indication: Hypertension

Metformin HCL
    Dosage: 2000 mg, daily
    Start date: 2008-01-01

Rasilez
    Dosage: 150 mg, daily
    End date: 2012-01-17

Diovan HCT
    Dosage: 320/25 mg, daily

Falithrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Thrombophlebitis Superficial
    Start date: 2009-01-01

Fluvastatin Sodium
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-01-01

Torsemide
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-01-01

Diovan HCT
    Dosage: 160 /25 mg, daily

Procoralan
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-01-01

Diovan HCT
    Dosage: 80 /25 mg, daily
    Indication: Cardiac Failure
    Start date: 2008-01-01

Glimepiride
    Dosage: 4 mg , daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2008-01-01

Bisoprolol Fumarate
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2008-01-01

Other drugs received by patient: Thienopyridine; Platelet Aggregation Inhibitors; Anticoagulants



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-03-14

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Coronary Artery Thrombosis, Left Ventricular Failure, Hypertensive Crisis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Rasilez
    Administration route: Oral
    Indication: Hypertension

Fluvastatin Sodium
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-01-01

Procoralan
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-01-01

Falithrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Thrombophlebitis Superficial
    Start date: 2009-01-01

Diovan HCT
    Dosage: 80 /25 mg, daily
    Indication: Cardiac Failure
    Start date: 2008-01-01

Diovan HCT
    Dosage: 160 /25 mg, daily

Bisoprolol Fumarate
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2008-01-01

Rasilez
    Dosage: 150 mg, daily
    End date: 2012-01-17

Diovan HCT
    Dosage: 320/25 mg, daily

Metformin HCL
    Dosage: 2000 mg, daily
    Start date: 2008-01-01

Torsemide
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-01-01

Glimepiride
    Dosage: 4 mg , daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2008-01-01

Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants



Possible Torsemide side effects in 45 year old male

Reported by a physician on 2012-01-31

Patient: 45 year old male

Reactions: Vomiting, Nausea, Hyperkalaemia, Hypotension, Hyperglycaemia, Headache, Treatment Noncompliance, Hyperhidrosis, Hypertensive Crisis, Carotid Artery Stenosis, Glycosylated Haemoglobin Increased, Vertigo, Dizziness, Fluid Intake Reduced, Influenza

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleglitazar (Aleglitazer)
    Dosage: see image
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Aleglitazar (Aleglitazer)
    Dosage: see image
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Spironolactone
    Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-04

Torsemide
    Dosage: 10 mg (10 mg,l in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Other drugs received by patient: Inegy(ezetimibe, Simvastatin); Diovan; Aspirin; Omega-3 Acid Ethyl Esters(omega-3 Acid Ethyl Esters); Amlodipine; Liprolog (Lispro Insulin); Aliskiren (Aliskiren Fumarate); Allopurinol; Hydrocrlorothiazide (Hydrochlorothiazide); Catapressan (Clonidine Hydrochloride); Colopidogrel Bisulfate(clopidogrel Bisulfate); Pantoprazole; Metformin HCL; Nitrolingual (Nitroglycerin); Levemir; Vildagliptin (Vildagliptin); Nebilet(nebivoloi Hydrochloride)



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-01-30

Patient: male

Reactions: Carotid Artery Stenosis, Hyperkalaemia, Hypertensive Crisis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torsemide
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Blinded Aleglitazar
    Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis

Spironolactone
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Amlodipine; Ezetimibe; Diovan; Amlodipine; Vildagliptin; Hydrochlorothiazide; Nitrolingual; Pantoprazole; Levemir; Aspirin; Clopidogrel; Metfformin Hydrochloride; Aliskiren; Catapres; Liprolog; Nebivolol HCL; Allopurinol; Diovan; Omega-3-Acid Ethyl Esters; Nitrolingual



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-01-26

Patient: male

Reactions: Carotid Artery Stenosis, Hyperkalaemia, Hypertensive Crisis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torsemide
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Blinded Aleglitazar
    Dosage: last dose prior to hyperkalaemia: 04/jul/2011, hypertensive crisis: 11/aug/2011
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis

Spironolactone
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Clopidogrel; Ezetimibe; Pantoprazole; Aliskiren; Nitrolingual; Amlodipine; Aspirin; Omega-3-Acid Ethyl Esters; Hydrochlorothiazide; Nebivolol HCL; Liprolog; Amlodipine; Diovan; Levemir; Vildagliptin; Catapres; Allopurinol; Metformin HCL; Nitrolingual; Diovan



Possible Torsemide side effects in 45 year old male

Reported by a physician on 2012-01-23

Patient: 45 year old male

Reactions: Vomiting, Nausea, Hyperkalaemia, Treatment Noncompliance, Hypertensive Crisis, Carotid Artery Stenosis, Renal Impairment, Glycosylated Haemoglobin Increased, Blood Glucose Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Dosage: 1 dosage forms (1 dosage forms, 1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-04

Torsemide
    Dosage: 10 mg (10 mg, 1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Aleglitazar (Aleglitazar)
    Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interuppted, frequency qd, o
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Aleglitazar (Aleglitazar)
    Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interuppted, frequency qd, o
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Other drugs received by patient: Allopurinol; Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters); Aliskiren (Aliskiren Fumarate); Catapressan (Clonidine Hydrochloride); Liprolog (Lispro Insulin); Aspirin; Levemir; Clopidogrel Bisulfate; Pantoprazole; Vildagliptin (Vildagliptin); Nitrolingual (Nitroglycerin); Nebivolol HCL; Inegy (Ezetimibe, Simvastatin); Amlodipine; Metformin HCL; Hydrochlorothiazide; Diovan



Possible Torsemide side effects in 45 year old male

Reported by a physician on 2012-01-05

Patient: 45 year old male

Reactions: Vomiting, Aortic Stenosis, Hyperkalaemia, Nausea, Hyperglycaemia, Hypertensive Crisis, Carotid Artery Stenosis, Renal Impairment, Blood Pressure Fluctuation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torsemide
    Dosage: 10 mg (10 mg, 1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Spironolactone
    Dosage: 1 dosage forms (1 dosage forms, 1 in1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-04

Aleglitazar (Aleglitazar)
    Dosage: oral (lst dose prior to hyperkalaemia
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Aleglitazar (Aleglitazar)
    Dosage: oral (lst dose prior to hyperkalaemia
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Other drugs received by patient: Liprolog (Lispro Insulin); Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters); Diovan; Aspirin; Inegy (Ezetimibe, Simvastatin); Clopidogrel Bisulfate; Allopurinol; Metformin HCL; Nebivolol HCL; Vildagliptin (Vildagliptin); Catapressan (Clonidine Hydrochloride); Nitrolingual (Nitroglycerin); Amlodipine; Pantoprazole; Levemir; Aliskiren (Aliskiren Fumarate); Hydrochlorothiazide



Possible Torsemide side effects in 45 year old male

Reported by a physician on 2011-10-12

Patient: 45 year old male

Reactions: Carotid Artery Stenosis, Renal Impairment, Vomiting, Hyperkalaemia, Hypertensive Crisis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleglitazar (Aleglitazar)
    Dosage: see image
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Aleglitazar (Aleglitazar)
    Dosage: see image
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Spironolactone
    Dosage: 1 dosage forms (1 dosage forms,1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-04

Torsemide
    Dosage: 10 mg (10 mg,1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08

Other drugs received by patient: Inegy (Ezetimibe, Simvastatin); Vildagliptin (Vildagliptin); Pantoprazole; Aliskiren (Aliskiren Fumarate); Catapressan (Clonidine Hydrochloride); Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters); Clopidogrel Bisulfate; Amlodipine; Levemir; Nitrolingual (Nitroglycerin); Metformin HCL; Liprolog (Lispro Insulin); Nebivolol HCL; Allopurinol; Aspirin; Hydrochlorothiazide; Diovan

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017